Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 4 Neoplasm Metastasis 3 Multiple Myeloma 3 Breast Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Melanoma 1 Malignant Solid Neoplasm 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Lung Neoplasms 1 Hematologic Neoplasms 1 HER2 Positive Breast Cancer 1 Glioma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1

Interventions

copanlisib 1 Trastuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

HER2 Positive Breast Cancer × copanlisib × 90 days × Clear all

NCT02705859 2026-04-13

Panther

Cancer Trials Ireland

Phase 1 Completed

HER2 Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡